NICE chief: NHS faces 'startling costs' from new treatments

By Sharon Brennan2018-06-07T05:58:00

The NHS faces a “material challenge” to fund new personalised drugs and deal with the “startling costs” of new medical technology, says the chief executive of the National Institute for Health and Care Excellence.

You need to be signed in to read more

Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

All of HSJ.co.uk and our HSJ mobile app
News and insight on all areas of public funded healthcare
Expert commentary, insight and analysis from industry leaders
9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

to HSJ

Sign into your account here